CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Interim results from the PACT-trial: High antiviral efficacy of daily consensus interferon/ribavirin compared to peg-interferon alfa2b/ribavirin in treatment-naive patients with chronic hepatitis C and serotype–2 or –3
DOI 10.1055/s-2005-920035
Bibliografische Angaben
Nachweis in CareLit
Autor:innenWO Böcher, M Fuchs, P Buggisch, S Kaiser, R Link, J Nalop, C Antoni, J Schlaak, T Witthöft, PR Galle, HF Löhr
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe04/2006
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Introduction: Consensus interferon (CIFN) is a synthetic type 1 interferon with enhanced in vitro activity compared to conventional IFN-alfa (IFNa). In the prospective, randomized multicenter PegIntron-Against-Consensus-Trial (PACT), the efficacy and safety of daily CIFN-treatment and ribavirin is compared to peg-IFNa2b plus ribavrin. Methods: 400 patients with chronic HCV infection and serotype–2 or –3 will randoml…
Zitieren
Zitierempfehlung
WO Böcher, M Fuchs, P Buggisch, S Kaiser, R Link, J Nalop, C Antoni, J Schlaak, T Witthöft, PR Galle, HF Löhr (2006) Interim results from the PACT-trial: High antiviral efficacy of daily consensus interferon/ribavirin compared to peg-interferon alfa2b/ribavirin in treatment-naive patients with chronic hepatitis C and serotype–2 or –3. Zeitschrift für Gastroenterologie (04). https://doi.org/10.1055/s-2005-920035
Mit CareLit weiterarbeiten